Spinal Cord Injury Clinical Trials
Guide to Experimental Treatments for SCI (2.4 MB PDF)
A public guide for people with spinal cord injury, their families, friends and caregivers provided by the ICCP.
CenterWatch Clinical Trials Listing Service
A wealth of information related to clinical trials, such as a listing of more than 41,000 industry and government sponsored clinical trials as well as new drug therapies. Designed to be a resource both for patients interested in participating in clinical trials and for research professionals.
The U.S. National Institutes of Health, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members and members of the public current information about clinical research studies.
Information for patients and caregivers on new clinical trials with news and announcements. Also contains a search utility, newsletter, FAQs, articles, and resources.
The Mount Sinai Medical Center and Kessler Institute for Rehabilitation Are Now Enrolling for Proneuron's Phase II Study of ProCord for Neurologically Complete Spinal Cord Injury
Update: "Proneuron has recently created a new web site for SCI patients and their families to learn more about enrollment into the Company's Phase II clinical trial for ProCord procedure for complete SCI. The URL is www.spinalcordtrial.com."
The Mount Sinai Medical Center (NYC) and Kessler Institute for Rehabilitation (West Orange, NJ) are now enrolling for Proneuron's Phase II trial of ProCord, for complete spinal cord injury. The official announcement was made at the Rally For the Cure, at the Winter Garden Financial Center in New York City.
"This collaborative effort between leading centers of care for persons who have sustained a spinal cord injury is a testimony to the importance of how 'working together we can make things happen'. This is the message for all professionals involved in the care of spinal cord injury," said Dr. Steven Kirshblum, Principal Investigator and Director of Spinal Cord Injury Service, Kessler Institute for Rehabilitation.
Patients found eligible for the study will be randomly assigned to either a treatment or control group. Patients in the control group will not receive the study treatment. All control and treatment patients will receive standard spinal cord injury care and rehabilitation and will receive follow-up testing for one year.
"We selected this venue to jointly announce the launch of this trial at our centers to draw attention to the importance of collaboration if we are to be successful. We need everyone to spread the word to doctors, family and friends so that we can reach people in the crucial first few days after their injury," said Dr. Kristjan Ragnarsson, the Principal Investigator and head of the Department of Rehabilitation Medicine at Mount Sinai.
This international, multi-center, randomized-controlled, experimental study is open to patients who meet eligibility criteria, including but not limited to an ASIA Grade A injury between C5-T11 vertebrae, within 14 days of injury. Asia Grade A is defined as patients who have no feeling or movement below the point of injury.
Telephone: 1 866 539 0767 (U.S. toll free) or 1 506 652 3486.
Fax: 1 866-214-7078
- Callers outside of the U.S., please use standard international dialing code
For additional information: www.proneuron.com